PACT - Public Activities Coordination Tool
PACT - Public Activities Coordination Tool
PACT - Public Activities Coordination Tool
The public activities coordination tool (PACT) provides an overview of the substance-specific activities that authorities are working on under REACH and the CLP Regulation. These activities are being carried out in line with ECHA’s Integrated Regulatory Strategy.
PACT provides up-to-date information on the activities planned, ongoing or completed by ECHA and/or MSCAs for a given substance in the following areas:
- Data generation and assessment – dossier evaluation, substance evaluation, informal hazard assessment (PBT/vPvB/ED).
- Assessment of regulatory needs (ARN).
- Regulatory risk management – harmonised classification and labelling (CLH) , SVHC identification, recommendations for inclusion in the Authorisation List, restriction.
A summary of all the substance-specific activities can be found under ‘Details’ for each entry.
Further information
- Understanding PACT
- Integrated Regulatory Strategy
- Substances of potential concern
- Dossier Evaluation status
- Substance evaluation
- Endocrine disruptor assessment
- PBT assessment
- Assessment of regulatory needs list
- Registry of CLH intentions until outcome
- Registry of SVHC intentions until outcome
- Recommendations for inclusion in the Authorisation list
- Registry of restriction intentions until outcome
Filter the list
The List does not contain any Substances.
| Data generation and assessment | ARN | Regulatory risk management | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2-hydroxy-p-toluic acid | 200-068-3 | 50-85-1 | - | - | 1 | - | 1 | - | - | - | - | Details |
| Glucose | 200-075-1 | 50-99-7 | - | - | - | - | 1 | - | - | - | - | Details |
| 2-(2-butoxyethoxy)ethyl 6-propylpiperonyl ether | 200-076-7 | 51-03-6 | 1 | - | 2 | - | - | 1 | - | - | - | Details |
| 2,4-dinitrophenol | 200-087-7 | 51-28-5 | - | - | - | - | - | 1 | - | - | - | Details |
| Dexamphetamine | 200-112-1 | 51-64-9 | - | - | - | - | 1 | - | - | - | - | Details |
| Bronopol | 200-143-0 | 52-51-7 | - | - | - | 1 | - | 1 | - | - | - | Details |
| Cysteine hydrochloride | 200-157-7 | 52-89-1 | - | - | 3 | - | - | - | - | - | - | Details |
| Nicotine | 200-193-3 | 54-11-5 | - | - | - | - | - | 1 | - | - | - | Details |
| Sodium salicylate | 200-198-0 | 54-21-7 | - | - | - | - | 1 | - | - | - | - | Details |
| Bis(4-hydroxy-N-methylanilinium) sulphate | 200-237-1 | 55-55-0 | 1 | - | - | - | - | - | - | - | - | Details |